Box score
Enveric Biosciences, Inc.
Reported $5M sold in a new Form D filed May 4, 2026 (Cambridge, Massachusetts).
- Biggest raise
- $5M filed May 4, 2026
- League
- Bio & Health Biotechnology
- Based in
- Cambridge, Massachusetts
- Season rank
- #318 of 1,121 in the Bio & Health League; #2788 of 10,745 overall (2026)
- Entity
- Corporation
Form D filings since 2024 4
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2026-05-04 | New notice | $5M | $5M | SEC |
| 2026-02-11 | New notice | $1.5M | $1.5M | SEC |
| 2025-12-23 | New notice | $107K | $107K | SEC |
| 2025-10-03 | New notice not ranked | $0 | indefinite | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 890821.
Similar raises, 2026
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Crosslink Therapeutics Inc. | Bio & Health | $5.5M |
| 2 | General Oncology, Inc. | Bio & Health | $4.8M |
| 3 | Fresenius Medical Care Northern Lancaster, LLC rookie | Bio & Health | $4.6M |
| 4 | 20 Bio, Inc. rookie | Bio & Health | $4.5M |
| 5 | Fresenius Medical Care Fulshear, LLC rookie | Bio & Health | $4.4M |
| 6 | Everest Biolabs, Inc. rookie | Bio & Health | $4.3M |